Form 4 for BFRI Biofrontera Inc.
Accepted 2022-09-19 00:00:00 ET · period of report 2022-07-01 · accession 0001493152-22-026176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-09-19 | 2022-07-01 | BFRI | Monaco Erica L. | CEO | M - OptEx | — | +56.7K | 56.7K | New | — |
| D | 2022-09-19 | 2022-07-01 | BFRI | Monaco Erica L. | CEO | M - OptEx | $0.00 | -56.7K | 152.7K | -27% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-07-01 | M | A | 56,689 | — | 56,689 | D | — | — | (F1) Restricted stock units covert into common stock on a one-for-one basis. |
| 2 | Derivative | Restricted Stock Units | 2022-07-01 | M | D | 56,689 | $0.00 | 152,672 | D | — · — to — | 56,689 Common Stock | (F1) Restricted stock units covert into common stock on a one-for-one basis. (F2) On December 9, 2021, the reporting person was granted 56,689 restricted stock units, vesting on the six-month anniversary of the grant date. |